The European Medical Technology Industry Association, Eucomed, has launched the third in a series of educational publications on medical technology innovation, focusing on minimally invasive surgery (MIS).
In recent years there has been a tremendous development in MIS, Eucomed points out. ‘Few areas of surgery do not currently benefit from advances in MIS. An MIS procedure is defined as one that is carried by entering the body through a small incision in the skin or, through a body cavity or anatomical opening, with the minimum damage possible. Resulting in far less trauma for the patient, MIS can also be less resource intensive, and could greatly reduce the patient’s time in hospital and speed up recovery times, generally causing a patient less pain and scarring. It might also reduce the incidence of post-surgical complications. It is important to note that MIS is not synonymous with minor surgery as it is now commonly used in serious and complex operations, such as heart surgery, Eucomed adds.
Other examples of procedural use: small bowel surgery, removal of kidney stones and tumours, brain surgery, carotid angioplasty, stenting, and knee replacements. Medical technology industry researchers are working to improve and refine MIS techniques.
A clinical trial has shown that post-thrombotic syndrome — a common and often painful complication after deep vein thrombosis — can be effectively treated with a minimally invasive procedure.
A small but growing body of evidence suggests that a minimally invasive surgical procedure called lymphovenous anastomosis (LVA) might be an effective treatment for Alzheimer's disease.
Even after a blood clot is removed from a large brain artery via thrombectomy, administering the thrombolytic drug alteplase to the area may improve stroke recovery, a new trial from Spain shows.
This website uses cookies to give our readers the best website experience. Please refer to our privacy policy to find out how we use cookies and how you can edit your preferences.